SSI developed in 2 of 100 patients ( 2 % ) in the antibiotic prophylaxis group and 13 of 100 patients ( 13 % ) in the placebo group , indicating a significant difference between the 2 groups ( relative risk ratio , 0.25 ; 95 % confidence interval , 0.070 to 0.92 ; P = .003 ) .